Ledger.Open graph →
SEC Form D · filed June 23, 2021

Lyndra Therapeutics, Inc

Offering
$65.0M
Sold
$60.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WATERTOWN, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Patricia S. Hurter · Watertown, MAExec · DirectorCatherine S. Reynolds · Watertown, MADirectorJessica G. Ballinger · Watertown, MAExecRobert S. Langer · Watertown, MADirectorCarlo G. Traverso · Watertown, MADirectorZafi S. Avnur · Watertown, MADirectorAmy Schulman · Watertown, MADirectorTodd Wheatley · Lowell, MAExec · DirectorAdrienne Becker · New York, NYDirectorMichael H. Richardson · ST. HELIER, Y9DirectorBakhtear Talukdar · Madison, WIExecJonathan Bombaci · Lowell, MADirectorMatthew Perimian · Lowell, MADirectorDestry Witt · Madison, WIDirectorAP GPE X GP Limited Partnership · Boston, MAExec · DirectorRichard Kane · Boston, MADirectorTimothy J. Ozanne · Bozeman, MTDirectorVikas L. Agrawal · ANN ARBOR, MIDirectorSergil R. Naviwala · Atlanta, GADirectorAnthony R. Tittanegro · Atlanta, GAExecPatrick R. Leardo · Atlanta, GADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗